Cel-Sci Corp. (CVM)

Cel-Sci (CVM) Stock Price & Analysis


CVM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.88 - $6.14
Previous Close$2.3
Average Volume (3M)131.88K
Market Cap
Enterprise Value$93.23M
Total Cash (Recent Filing)$22.67M
Total Debt (Recent Filing)$15.30M
Price to Earnings (P/E)-2.7
May 16, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.85
Shares Outstanding43,738,865
10 Day Avg. Volume114,168
30 Day Avg. Volume131,882
Standard Deviation0.43
Financial Highlights & Ratios
Price to Book (P/B)3.75
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-5.30
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.00
Price Target Upside331.03% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Cel-Sci Corp.’s price range in the past 12 months?
Cel-Sci Corp. lowest stock price was $1.88 and its highest was $6.14 in the past 12 months.
    What is Cel-Sci Corp.’s market cap?
    Currently, no data Available
    When is Cel-Sci Corp.’s upcoming earnings report date?
    Cel-Sci Corp.’s upcoming earnings report date is May 16, 2023 which is in 46 days.
      How were Cel-Sci Corp.’s earnings last quarter?
      Cel-Sci Corp. released its earnings results on Feb 15, 2023. The company reported -$0.18 earnings per share for the quarter, missing the consensus estimate of -$0.16 by -$0.02.
        Is Cel-Sci Corp. overvalued?
        According to Wall Street analysts Cel-Sci Corp.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cel-Sci Corp. pay dividends?
          Cel-Sci Corp. does not currently pay dividends.
          What is Cel-Sci Corp.’s EPS estimate?
          Cel-Sci Corp.’s EPS estimate is -$0.17.
            How many shares outstanding does Cel-Sci Corp. have?
            Cel-Sci Corp. has 43,738,865 shares outstanding.
              What happened to Cel-Sci Corp.’s price movement after its last earnings report?
              Cel-Sci Corp. reported an EPS of -$0.18 in its last earnings report, missing expectations of -$0.16. Following the earnings report the stock price went down -0.376%.
                Which hedge fund is a major shareholder of Cel-Sci Corp.?
                Among the largest hedge funds holding Cel-Sci Corp.’s share is Perceptive Advisors LLC. It holds Cel-Sci Corp.’s shares valued at N/A.


                  Cel-Sci Stock Smart Score

                  The Cel-Sci stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Cel-Sci Corp.

                  CEL-SCI Corp. is a biotechnology company, which engages in the research, development, and manufacture of investigational immunotherapy products for the treatment of cancer and infectious diseases. Its product pipeline includes Multikine and Ligand Epitope Presentation System (LEAPS). Multikine is an investigational immunotherapy for the potential treatment of head and neck cancers. LEAPS is categorized into LEAPS-H1N1-DC, a product candidate for the treatment of pandemic influenza for hospitalized patients; and CEL-2000 and CEL-4000 which are vaccine candidates for the treatment of rheumatoid arthritis. The company was founded by Maximilian de Clara on March 22, 1983 and is headquartered in Vienna, VA.


                  Top 5 ETFs holding CVM

                  Market Value
                  Smart Score
                  iShares Core S&P Total U.S. Stock Market ETF
                  Up to five ETFs with an Outperform Smart Score that hold CVM. The ETFs are listed according to market value of CVM within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Ovid Therapeutics
                  X4 Pharmaceuticals
                  KalVista Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis